LASS5 Antikörper (AA 101-200) (Cy5.5)
Kurzübersicht für LASS5 Antikörper (AA 101-200) (Cy5.5) (ABIN709411)
Target
Alle LASS5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 101-200
-
Spezifität
- Possible cross-reactivity with CERS6/LASS6 (85 % homology with the immunogen sequence)
-
Kreuzreaktivität
- Maus
-
Homologie
- Human,Rat,Dog,Cow,Pig,Horse,Chicken
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human LASS5
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- LASS5 (LAG1 Homolog, Ceramide Synthase 5 (LASS5))
-
Andere Bezeichnung
- LASS5
-
Hintergrund
-
Synonyms: LAG1 homolog ceramide synthase 5, LAG1 longevity assurance homolog 5, MGC45411, Trh4, CerS5, FLJ25304, CERS5_HUMAN.
Background: Lass5, or LAG1 longevity assurance homolog 5, is thought to be either a bona fide (dihydro)ceramide synthase or a modulator of its activity. When overexpressed in cells is involved in the production of sphingolipids containing mainly one fatty acid donnor ceramide) in a fumonisin B1-independent manner.
-
Gen-ID
- 55890
-
UniProt
- Q8N5B7
Target
-